Cognitive Variability Predicts Incident Alzheimer’s Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker.

Gleason, C., D. Norton, E. Anderson, M. Wahoske, D. Washington, E. Umucu, R. Koscik, N. Dowling, S. Johnson, C. Carlsson, S. Asthana, and D. Alzheimer’s. “Cognitive Variability Predicts Incident Alzheimer’s Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker.”. Journal of Alzheimer’s Disease : JAD, Vol. 61, no. 1, 2018, pp. 79-89.

Alzheimer’s disease (AD) biomarkers are emerging as critically important for disease detection and monitoring. Most biomarkers are obtained through invasive, resource-intense procedures. A cognitive marker, intra-individual cognitive variability (IICV) may provide an alternative or adjunct marker of disease risk for individuals unable or disinclined to undergo lumbar puncture.

DOI: 10.3233/JAD-170498

PubMed: 29125485